I was reading through the report expecting to see a summary of what we already know when I came across this line:
"Moving forward, Prima looks to monetize our assets (such as our products and technology) through commercial partnerships or licenses..."
Have I missed something? I thought we were heading towards a manufacturer/distributor model but this suggests otherwise. If this is a change, then I see it as the first indication of a deal with Big Pharma is in the pipeline already.
Ann: Half Yearly Report and Accounts , page-2
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 34.5¢ | 35.0¢ | 33.5¢ | $724.1K | 2.106M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 60483 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 55452 | 4 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |